These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 23983688)

  • 1. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors.
    Westley RL; May FE
    Int J Endocrinol; 2013; 2013():632461. PubMed ID: 23983688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus.
    Lewitt MS; Dent MS; Hall K
    J Clin Med; 2014 Dec; 3(4):1561-74. PubMed ID: 26237614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low concentrations of insulin-like growth factor-I in abdominal obesity.
    Mårin P; Kvist H; Lindstedt G; Sjöström L; Björntorp P
    Int J Obes Relat Metab Disord; 1993 Feb; 17(2):83-9. PubMed ID: 8384169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?
    Scalera A; Tarantino G
    World J Gastroenterol; 2014 Jul; 20(28):9217-28. PubMed ID: 25071314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Talk between Adiponectin and IGF-IR in Breast Cancer.
    Mauro L; Naimo GD; Ricchio E; Panno ML; Andò S
    Front Oncol; 2015; 5():157. PubMed ID: 26236690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes.
    Jeyaratnaganthan N; Højlund K; Kroustrup JP; Larsen JF; Bjerre M; Levin K; Beck-Nielsen H; Frago S; Hassan AB; Flyvbjerg A; Frystyk J
    Growth Horm IGF Res; 2010 Jun; 20(3):185-91. PubMed ID: 20110184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and endocrine-related cancer: The important role of IGF-1.
    Zhong W; Wang X; Wang Y; Sun G; Zhang J; Li Z
    Front Endocrinol (Lausanne); 2023; 14():1093257. PubMed ID: 36755926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor.
    Gallagher EJ; Alikhani N; Tobin-Hess A; Blank J; Buffin NJ; Zelenko Z; Tennagels N; Werner U; LeRoith D
    Diabetes; 2013 Oct; 62(10):3553-60. PubMed ID: 23835331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine insulin receptor and insulin-like growth factor-1 receptor expression in digital lamellar tissue and insulin target tissues.
    Kullmann A; Weber PS; Bishop JB; Roux TM; Norby B; Burns TA; McCutcheon LJ; Belknap JK; Geor RJ
    Equine Vet J; 2016 Sep; 48(5):626-32. PubMed ID: 26095356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1 and IGF-2 as Molecules Linked to Causes and Consequences of Obesity from Fetal Life to Adulthood: A Systematic Review.
    Szydlowska-Gladysz J; Gorecka AE; Stepien J; Rysz I; Ben-Skowronek I
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of insulin receptors and IGF-I receptors in cancer and other diseases.
    Frasca F; Pandini G; Sciacca L; Pezzino V; Squatrito S; Belfiore A; Vigneri R
    Arch Physiol Biochem; 2008 Feb; 114(1):23-37. PubMed ID: 18465356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.
    Zhou W; Rowitz BM; Dailey MJ
    Exp Biol Med (Maywood); 2018 Jul; 243(11):911-916. PubMed ID: 29950119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human insulin-like growth factor-I: a therapeutic challenge for diabetes mellitus.
    Froesch ER; Hussain M
    Diabetologia; 1994 Sep; 37 Suppl 2():S179-85. PubMed ID: 7821734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.